FDA Reclassification of Rapid Antigen Flu Testing

 

FDA reclassification of rapid flu antigen testing

Please join Frederick S. Nolte, Ph.D., D(ABMM), F(AAM), Professor and Vice Chair for Laboratory Medicine in the Department of Pathology and Laboratory Medicine, and Medical Director of Clinical Laboratories, Molecular Pathology Laboratory and Point-Care-Testing at the Medical University of South Carolina, as he shares his insight regarding the recent FDA reclassification of Rapid Antigen flu testing, and why it's an opportunity for lab leadership.

 

Previous Article
Unveiling the Future of Laboratory Medicine
Unveiling the Future of Laboratory Medicine

Next Article
A New Year's Resolution: Become a Better Antibiotic Steward
A New Year's Resolution: Become a Better Antibiotic Steward

Please join Amesh Adalja, MD, FACP, Senior Associate, UPMC Center for Health Security, as he outlines what ...

×

LabLeaders.com has a new home. Tell us a bit about yourself.

First Name
Last Name
Mobile Phone Number
Thank you!
Error - something went wrong!